Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study

BACKGROUND: It has been suggested that ergoline dopamine agonists can cause ischemic complications. The effect of dopamine agonists in general on the prevalence of ischemic events in patients with Parkinson’s disease (PD) has not been studied. OBJECTIVE: Our aim was to investigate the association be...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbouw, Maurits E. L., Movig, Kris L. L., Guchelaar, Henk-Jan, Neef, Cees, Egberts, Toine C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249169/
https://www.ncbi.nlm.nih.gov/pubmed/21779969
http://dx.doi.org/10.1007/s00228-011-1084-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249169/
https://www.ncbi.nlm.nih.gov/pubmed/21779969
http://dx.doi.org/10.1007/s00228-011-1084-6

Ejemplares similares